ANGPTL8 Levels Associated with Hyperlipidemia in Primary Nephrotic Syndrome
|
By LabMedica International staff writers Posted on 28 Apr 2021 |

Image: The FUS-2000 automated urine analyzer (Photo courtesy of DIRUI)
The typical clinical manifestations of Primary Nephrotic Syndrome (PNS) include massive proteinuria, hypoproteinemia, edema and/or hyperlipidemia. Of these, marked proteinuria is the core clinical manifestation, and its severity often parallels the degree of hyperlipidemia.
Members of the angiopoietin-like protein (ANGPTL) family are mainly involved in vascular endothelial genesis and the regulation of lipid metabolism. Recent studies have detected ANGPTL8 in human and mouse serum, and moderate levels have been found in human urine. Studies have confirmed that ANGPTL8, ANGPTL4, and ANGPTL3 synergistically interact to participate in fatty acid transfer.
Nephrologists at the Guangzhou Women and Children's Medical Center (Guangzhou City, China) and their associates recruited 193 subjects including 133 patients with PNS and 60 healthy controls (HCs). The levels of serum cholesterol (CHOL), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), LDL-C, albumin (ALB), creatinine (CREA), urea (Ur) were measured by ARCHITECT c1600 automated biochemical analyzer (Abbott, Abbott Park, IL, USA). 24-hour urine total protein (24 hUTP), urine creatinine (UCr) were measured by the UniCel DxI 800 automated chemiluminescence immunoanalyzer (Beckman Coulter, Brea, CA, USA), and urine protein was measured by FUS-2000 automated urine analyzer (DIRUI, Changchun, China). The serum and urine ANGPTL8 concentrations were measured with ELISA kits.
The team reported that compared with healthy controls, subjects with primary nephrotic syndrome had higher levels of serum and urine ANGPTL8. In primary nephrotic syndrome patients, serum ANGPTL8 was positively correlated with cholesterol and triglycerides, while there was no correlation with 24 hour UTP. Urine ANGPTL8 was positively correlated with high-density lipoprotein cholesterol (and was significantly negatively correlated with creatinine, eGFR and 24 hour UTP. The urine ANGPTL8 concentrations in membranous nephropathy and mesangial proliferative glomerulonephritis pathological types were different.
The authors concluded that serum and urine ANGPTL8 levels in primary nephrotic syndrome patients were correlated with blood lipid levels and proteinuria, respectively, suggesting that ANGPTL8 may play a role in the development of primary nephrotic syndrome hyperlipidemia and proteinuria. The study was published on April 14, 2021 in the journal BMC Nephrology.
Related Links:
Guangzhou Women and Children's Medical Center
Abbott
Beckman Coulter
DIRUI
Members of the angiopoietin-like protein (ANGPTL) family are mainly involved in vascular endothelial genesis and the regulation of lipid metabolism. Recent studies have detected ANGPTL8 in human and mouse serum, and moderate levels have been found in human urine. Studies have confirmed that ANGPTL8, ANGPTL4, and ANGPTL3 synergistically interact to participate in fatty acid transfer.
Nephrologists at the Guangzhou Women and Children's Medical Center (Guangzhou City, China) and their associates recruited 193 subjects including 133 patients with PNS and 60 healthy controls (HCs). The levels of serum cholesterol (CHOL), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), LDL-C, albumin (ALB), creatinine (CREA), urea (Ur) were measured by ARCHITECT c1600 automated biochemical analyzer (Abbott, Abbott Park, IL, USA). 24-hour urine total protein (24 hUTP), urine creatinine (UCr) were measured by the UniCel DxI 800 automated chemiluminescence immunoanalyzer (Beckman Coulter, Brea, CA, USA), and urine protein was measured by FUS-2000 automated urine analyzer (DIRUI, Changchun, China). The serum and urine ANGPTL8 concentrations were measured with ELISA kits.
The team reported that compared with healthy controls, subjects with primary nephrotic syndrome had higher levels of serum and urine ANGPTL8. In primary nephrotic syndrome patients, serum ANGPTL8 was positively correlated with cholesterol and triglycerides, while there was no correlation with 24 hour UTP. Urine ANGPTL8 was positively correlated with high-density lipoprotein cholesterol (and was significantly negatively correlated with creatinine, eGFR and 24 hour UTP. The urine ANGPTL8 concentrations in membranous nephropathy and mesangial proliferative glomerulonephritis pathological types were different.
The authors concluded that serum and urine ANGPTL8 levels in primary nephrotic syndrome patients were correlated with blood lipid levels and proteinuria, respectively, suggesting that ANGPTL8 may play a role in the development of primary nephrotic syndrome hyperlipidemia and proteinuria. The study was published on April 14, 2021 in the journal BMC Nephrology.
Related Links:
Guangzhou Women and Children's Medical Center
Abbott
Beckman Coulter
DIRUI
Latest Immunology News
- Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
- Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
- Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
- Blood Test Could Identify Colon Cancer Patients to Benefit from NSAIDs
- Blood Test Could Detect Adverse Immunotherapy Effects
- Routine Blood Test Can Predict Who Benefits Most from CAR T-Cell Therapy
- New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
- Gene Signature Test Predicts Response to Key Breast Cancer Treatment
- Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
- Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
- Signature Genes Predict T-Cell Expansion in Cancer Immunotherapy
- Molecular Microscope Diagnostic System Assesses Lung Transplant Rejection
- Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer
- Luminescent Probe Measures Immune Cell Activity in Real Time
- Blood-Based Immune Cell Signatures Could Guide Treatment Decisions for Critically Ill Patients
- Novel Tool Predicts Most Effective Multiple Sclerosis Medication for Patients
Channels
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







